# CBD for Dental Pain

> **NCT04642404** · PHASE1,PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 64 (actual)

## Conditions studied

- Odontalgia
- Toothache

## Interventions

- **DRUG:** Epidiolex 100 mg/mL Oral Solution
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04642404
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-01
- **Primary completion:** 2023-03-02
- **Final completion:** 2023-03-13
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2024-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04642404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04642404, "CBD for Dental Pain". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04642404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*